Mental health issues and sleep disorders have seen a significant surge globally, particularly in the aftermath of the COVID-19 pandemic. The impact on productivity and healthcare costs has been substantial. In Thailand, the prevalence of depression and insomnia has risen dramatically, affecting over 19 million individuals. The search for safer, natural solutions to these issues has led researchers to investigate the potential benefits of spirulina, a blue-green algae rich in tryptophan.
What is Spirulina?
Spirulina is a microalgae that is high in tryptophan, an amino acid essential for the production of serotonin and melatonin, neurotransmitters that regulate mood and sleep-wake cycles. It is commonly found in dietary supplements in the form of tablets or capsules. Spirulina also contains a range of vitamins, minerals, and antioxidants, including B vitamins, iron, magnesium, and carotenoids.
Benefits of Spirulina on Sleep and Mental Health
Early studies have suggested that spirulina may have a positive effect on sleep quality and stress management. However, no clinical trials have tested its effects on adults with mild to moderate depression. Researchers at Mahidol University, Suranaree University of Technology, and Chiang Mai University conducted a new double-blind, placebo-controlled trial to investigate the effects of spirulina on sleep quality and mental health.
Study Participants and Methodology
The study enrolled 60 healthy adults aged 18 to 60 with mild to moderate depression and a BMI under 30. Participants were excluded if they were pregnant or breastfeeding, night shift workers, severe psychiatric cases, heavy smokers or drinkers, recent travelers, or using sleep or weight-loss supplements. The randomized, placebo-controlled trial used blinded group assignments and assessed mental health, sleep quality, and sleep hygiene at baseline, week 4, and week 8.
Results and Findings
The study found that participants taking spirulina had significantly better sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI) scores. Those taking spirulina also experienced improved sleep latency, meaning they took less time to fall asleep. The results showed that the spirulina group had a mean PSQI score of 4.97, down from 7.03 at baseline, whereas the placebo group had a mean score of 6.73 at week 8. In addition to sleep benefits, the participants’ mental health status improved with spirulina. Scores on the Depression Anxiety Stress Scales (DASS-21) decreased steadily in the spirulina group, from an average of 19 (mild-moderate range) at the start to 12 by week 8. The placebo group’s DASS scores showed a slight increase by the end of the study.
Weight and Blood Pressure Changes
Despite the positive effects on sleep and mood, spirulina supplementation did not significantly affect BMI and blood pressure in either group. This suggested that the daily dose of spirulina did not lead to weight loss or gain or alter blood pressure in this short timeframe.
Trial adherence was high, with only two participants in the spirulina group missing any doses (one day and three days out of 56 days in total). 95% of the enrolled subjects completed the eight-week trial. The spirulina softgel was well tolerated, with no severe adverse effects reported during the study.
The study authors suggested that longer trials were needed to confirm and extend the results. Future research could explore higher doses, different populations, or combine spirulina with other interventions. They concluded that supplementing with spirulina may be an effective way to improve sleep quality and mental health, particularly for individuals with mild to moderately severe depression.
The findings of this study highlight the potential benefits of spirulina on sleep quality and mental health. While more research is needed to confirm the results, spirulina may be a promising solution for individuals seeking a natural alternative to address mental health issues and sleep disorders.
Related Articles
